Avalo Therapeutics (AVTX) stock surges as Wedbush initiates with a bullish view, citing lead asset AVTX-009's potential against hidradenitis suppurativa. Read more here.

If the Department of Defense goes through budget cuts as suggested by a leaked memo, Palantir Technologies (PLTR) would have ...

The app’s availability in the U.S. has been thrown into jeopardy over data privacy and national security concerns.

Elon Musk is not interested in buying video-sharing platform TikTok, the CEO of Tesla and SpaceX said during a virtual ...

Elon Musk claims that he does not plan to purchase the TikTok app from the Chinese company ByteDance, thereby denying earlier ...

Elon Musk has dismissed speculation that he is interested in acquiring TikTok, denying reports that Chinese officials had ...

ByteDance has said it doesn’t have plans to sell ... are estimated to be worth between $40 billion and $50 billion, according ...

Wedbush analyst Nick Setyan upgraded Denny’s (DENN) to Outperform from Neutral with a price target of $10, up from $6. First, the firm believes Keke’s is meaningfully undervalued and ...

ByteDance's AI model OmniHuman-1 creates realistic videos from photos and sound bites, excelling in generating human videos with high quality. In a recently published technical paper, ByteDance ...

Alphabet Inc. (NASDAQ:GOOG – Free Report) – Analysts at Wedbush boosted their Q1 2025 ... Finally, Phillip Securities raised shares of Alphabet to a “strong-buy” rating in a research ...

Wedbush analyst David Nierengarten last night initiated coverage of Bicara Therapeutics (BCAX) with an Outperform rating and $31 price target The firm views the shares as an opportunity to own a ...

Airbnb (NASDAQ:ABNB – Get Free Report)‘s stock had its “outperform” rating reiterated by research analysts at Wedbush in a ... Phillip Securities restated a “reduce” rating and issued ...